Company Filing History:
Years Active: 2018
Title: Rolf Hilfiker: Innovator in Pharmaceutical Formulations
Introduction
Rolf Hilfiker is a notable inventor based in Kaiseraugst, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable formulations. With a total of 2 patents, his work has had a meaningful impact on the industry.
Latest Patents
Hilfiker's latest patents focus on a polymorphic form of [5-fluoro-3-({2-[(4-fluorobenzene)sulfonyl]pyridin-3-yl}methyl)-2-methylindol-1-yl]-acetic acid. The first patent describes a polymorphic form that is stable at room temperature, making it useful for preparing stable pharmaceutical formulations. The second patent highlights a polymorphic form that exhibits higher solubility than other forms, further enhancing its utility in pharmaceutical applications.
Career Highlights
Throughout his career, Rolf Hilfiker has worked with prominent companies in the pharmaceutical sector. Notably, he has been associated with Atopix Therapeutics Limited and Chiesi Farmaceutici S.p.a. His expertise in the field has allowed him to contribute to innovative solutions in drug formulation.
Collaborations
Hilfiker has collaborated with various professionals in the industry, including his coworker Katja Grosse-Sender. These collaborations have played a crucial role in advancing his research and development efforts.
Conclusion
Rolf Hilfiker's contributions to pharmaceutical innovations, particularly through his patents, demonstrate his commitment to improving drug formulations. His work continues to influence the industry positively.